SCPX Scorpius Holdings, Inc: Net earnings per share for the last four quarters

Scorpius Holdings Inc. (SCPX) - corporate logo

Scorpius Holdings, Inc. (SCPX) is developing innovative CDMO technologies for cell line automation. The company's revenue is based on the contract manufacturing of biologics and laboratory research. On GURU.Markets, the historical EPS YoY TTM delta demonstrates profit dynamics, where shows the level of this metric. Current testing services provide stability, although large-scale growth catalysts are expected in the future.

SCPX (Scorpius Holdings) Earnings per share for the last twelve months history from 07/04/2022 to 11/18/2026

nighthawkbio.com - analytical breakdowns and key metrics (SCPX)

Initial company analysis:SCPX, Scorpius Holdings Inc.
Original product of Scorpius Holdings, Inc.

Scorpius Holdings, Inc. (SCPX) is developing a vertically integrated CDMO platform to accelerate the production of biopharmaceuticals. This indicator reflects the dynamics of net earnings per share over the last twelve months relative to the previous year. By analyzing the annual EPS TTM delta, an investor can observe a smoothed profitability trajectory devoid of market noise. This allows for an assessment of the efficiency of the company's production capacity scaling. Stable growth of this metric confirms the fundamental resilience of the business within the biotechnology sector.